Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1990-4-19
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1060-913X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
443-62
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:2156307-Antiviral Agents,
pubmed-meshheading:2156307-Epidemiologic Factors,
pubmed-meshheading:2156307-Hepatitis, Chronic,
pubmed-meshheading:2156307-Hepatitis B,
pubmed-meshheading:2156307-Humans,
pubmed-meshheading:2156307-Immune System,
pubmed-meshheading:2156307-Immunotherapy,
pubmed-meshheading:2156307-Prognosis
|
pubmed:year |
1990
|
pubmed:articleTitle |
Chronic hepatitis B.
|
pubmed:publicationType |
Journal Article,
Review
|